NCT06565442View on ClinicalTrials.gov

Feasibility of Using NeuraSignal Transcranial Doppler Robot

Not yet recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

December 15, 2025

Primary Completion Date

July 14, 2026

Study Completion Date

December 15, 2027

Conditions
Cerebral Autoregulation
Interventions
DEVICE

NeuraSignal transcranial doppler robot

measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves

Trial Locations (1)

35249

UAB Department of Anesthesiology and Perioperative Medicine, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT06565442 - Feasibility of Using NeuraSignal Transcranial Doppler Robot | Biotech Hunter | Biotech Hunter